Hans‐Henrik Parving
- Endocrinology, Diabetes and Metabolism top 0.05%
- Cardiology and Cardiovascular Medicine top 0.1%
- Nephrology top 0.02%
- Molecular Biology top 2%
- Surgery top 1%
- Co-authors
- Peter RossingOluf PedersenLise TarnowPeter GædeHenrik Lund‐AndersenSteen AndersenPeter HovindKasper Rossing
- Topics
- Chronic Kidney Disease and Diabetes (94 papers)Blood Pressure and Hypertension Studies (93 papers)Diabetes Treatment and Management (42 papers)
- Partner nations
- DenmarkNetherlandsUnited States
In The Last Decade
Hans‐Henrik Parving
232 papers receiving 19.9k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Endocrinology, Diabetes and Metabolism 8.9k
- Cardiology and Cardiovascular Medicine 8.4k
- Nephrology 7.4k
- Molecular Biology 2.8k
- Surgery 2.2k
Countries citing papers authored by Hans‐Henrik Parving
This map shows the geographic impact of Hans‐Henrik Parving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Henrik Parving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Henrik Parving more than expected).
Fields of papers citing papers by Hans‐Henrik Parving
This network shows the impact of papers produced by Hans‐Henrik Parving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Henrik Parving. The network helps show where Hans‐Henrik Parving may publish in the future.
Co-authorship network of co-authors of Hans‐Henrik Parving
This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Henrik Parving. A scholar is included among the top collaborators of Hans‐Henrik Parving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Henrik Parving. Hans‐Henrik Parving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 5 | |
| 3 | 43 | |
| 4 | 23 | |
| 5 | 56 | |
| 6 | 12 | |
| 7 | 10 | |
| 8 | 15 | |
| 9 | 19 | |
| 10 | 17 | |
| 11 | 71 | |
| 12 | [Aliskiren combined with losartan in type 2-diabetes and nephropathy - secondary publication]. | 5 |
| 13 | 88 | |
| 14 | Abstract 426: The Diovan Reduction Of Proteinutria (Drop) Study: Albuminuria Response to High-Doses Of Valsartan in Type 2 Diabetes Mellitus | 4 |
| 15 | 13 | |
| 16 | 64 | |
| 17 | 52 | |
| 18 | 5 | |
| 19 | 43 | |
| 20 | 3 |
About Hans‐Henrik Parving
Hans‐Henrik Parving is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 232 papers that have together received 20.8k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (94 papers), Blood Pressure and Hypertension Studies (93 papers) and Diabetes Treatment and Management (42 papers). The work is most often cited by research in Nephrology (7.4k citations), Endocrinology, Diabetes and Metabolism (8.9k citations) and Cardiology and Cardiovascular Medicine (8.4k citations). Hans‐Henrik Parving has collaborated with scholars based in Denmark, Netherlands and United States. Frequent co-authors include Peter Rossing, Oluf Pedersen, Lise Tarnow, Peter Gæde, Henrik Lund‐Andersen, Steen Andersen, Peter Hovind, Kasper Rossing, Jens Brøchner‐Mortensen and Ramón Gomis. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.